DENTSPLY SIRONA earnings release, May 5, 2026
Dentsply Sirona Reports First Quarter 2026
Results
News Summary
• Reported net sales of $880 million
• Delivered GAAP gross margin of 48.5%, GAAP net loss per share of ($0.05)
• Achieved adjusted gross margin of 50.7%, adjusted EBITDA margin of 14.7%, adjusted EPS of $0.27
• Launched Smart View-Detect, the world's first FDA-cleared, AI-enabled diagnostic aid designed to identify teeth with periapical radiolucencies (PARL) in CBCT scans, now also CE-marked for use across Europe
• Continued to penetrate connected technology solutions market with new Atlanta Dental Supply distributor agreement
• Installed first CEREC® system under the new Benco Dental distribution agreement, marking an important early milestone
• Began implementing new capital allocation strategy by reducing debt, managing liquidity, and improving working capital
• Reiterated 2026 outlook for net sales and adjusted EPS
Charlotte, N.C., May 5, 2026 -
DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2026.
“We are executing our Return-to-Growth Action Plan as expected, and our first quarter results reflect our current stage of transformation,” said Dan Scavilla, President and Chief Executive Officer of Dentsply Sirona. “While near-term performance is impacted by external pressures and investment timing, we are making solid progress toward sustainable growth.
"During the quarter, we advanced our commercial restructuring and continued portfolio innovation, with early traction from distributor partners. We remain confident in our strategy, maintain our full-year outlook, and expect momentum to build throughout the year.”
Q1 2026 Summary Results (Reported)
Q1 2026 Summary Results (Non-GAAP)
NM - not meaningful
Percentages are based on actual values and may not reconcile due to rounding.
[1]
Weighted-average shares outstanding used to calculate diluted loss per share for the first quarter of 2026 excludes potential dilutive common shares.
New Regional Reporting
Beginning in the three months ended March 31, 2026, the Company's geographic regions for reporting net sales were revised to consist of countries in (i) North and South America ("Americas"), (ii) Europe, the Middle East, and Africa ("EMEA"), and (iii) Asia Pacific ("APAC"). The revised regions align with how the Company manages commercial activities and reports net sales internally. This change did not impact the Company's consolidated financial statements and prior period amounts have been recast to conform to the current period presentation.
Cash Flow and Liquidity
Operating cash flow in the first quarter of 2026 was $40 million, compared to $7 million in the first quarter of 2025, primarily due to favorable collections on accounts receivable. Free cash flow, a Non-GAAP measure, in the first quarter of 2026 was ($12) million compared to ($12) million in the first quarter of 2025. The Company had $190 million of cash and cash equivalents as of March 31, 2026.
2026 Outlook
The Company is maintaining its 2026 outlook for net sales in the range of $3.5 billion to $3.6 billion and adjusted EPS in the range of $1.40 to $1.50.
We are unable to present a quantitative reconciliation of our expected earnings per diluted share to expected adjusted earnings per diluted share as we are unable to predict with reasonable certainty and without unreasonable effort, items which may include, but are not limited to, restructuring charges, transformation-related costs, impairment charges, certain tax adjustments, and other significant items. The financial impact of these items is uncertain and is dependent on various factors, including timing, and could be material to our Consolidated Statements of Operations.
Conference Call/Webcast Information
Dentsply Sirona's management team will host an investor conference call and live webcast on May 5, 2026, at 4:30 p.m. ET. The live webcast and a presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com.
For those planning to participate on the call, please register at http://register-conf.media-server.com/register/BIc1c93f4a84c14e3ea70e14bf07b0e306. A webcast replay of the conference call will be available on the Investors section of the Company's website following the call.
About Dentsply Sirona
Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona's innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company's shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Contact Information:
Investors:
Wade Moody
Senior Manager, Investor Relations
Investorrelations@dentsplysirona.com
Press:
Marion Par-Weixlberger
Vice President, Public Relations, Corporate Communications & Brand
Publicrelations@dentsplysirona.com
Financial statements
Income Statement
Twelve Months Ended December 31, 2024
| Twelve Months Ended December 31, 2024 – Gross Profit | Twelve Months Ended December 31, 2024 – Operating (Loss) Income | Twelve Months Ended December 31, 2024 – (Benefit) Provision for Income Taxes | Twelve Months Ended December 31, 2024 – Net (Loss) Income Attributable to Dentsply Sirona | Twelve Months Ended December 31, 2024 – Diluted (Loss) Earnings per Share | ||
|---|---|---|---|---|---|---|
| GAAP | 1,958 | -879 | -26 | -910 | -4.48 | |
| Non-GAAP Adjustments: | Amortization of Purchased Intangible Assets | 122 | 216 | 57 | 159 | 0.78 |
| Non-GAAP Adjustments: | Restructuring-Related Charges and Other Costs (a) | 6 | 136 | 30 | 106 | 0.53 |
| Non-GAAP Adjustments: | Goodwill and Intangible Asset Impairments | 1,014 | 144 | 870 | 4.27 | |
| Non-GAAP Adjustments: | Business Combination-Related Costs and Fair Value Adjustments | 2 | 4 | 1 | 3 | 0.01 |
| Non-GAAP Adjustments: | Fair Value and Credit Risk Adjustments | 2 | 0.01 | |||
| Non-GAAP Adjustments: | Income Tax-Related Adjustments (b) | -99 | 99 | 0.49 | ||
| Non-GAAP Adjustments: | Adjusted Non-GAAP | 2,088 | 491 | 107 | 329 | 1.61 |
| Non-GAAP Adjustments: | GAAP Margin | -23.2 | ||||
| Non-GAAP Adjustments: | Adjusted Non-GAAP Margin | 12.9 |
Income Statement
Three Months Ended June 30, 2025 — Percentages are based on actual values and may not reconcile due to rounding.
| Three Months Ended June 30, 2025 – Gross Profit | Three Months Ended June 30, 2025 – Operating (Loss) Income | Three Months Ended June 30, 2025 – (Benefit) Provision for Income Taxes | Three Months Ended June 30, 2025 – Net (Loss) Income Attributable to Dentsply Sirona | Three Months Ended June 30, 2025 – Diluted (Loss) Earnings per Share | ||
|---|---|---|---|---|---|---|
| GAAP | 490 | -128 | -109 | -45 | -0.22 | |
| Non-GAAP Adjustments: | Amortization of Purchased Intangible Assets | 32 | 54 | 14 | 40 | 0.2 |
| Non-GAAP Adjustments: | Restructuring-Related Charges and Other Costs (a) | 5 | 1 | 4 | ||
| Non-GAAP Adjustments: | Goodwill and Intangible Asset Impairments | 235 | 21 | 214 | 1.07 | |
| Non-GAAP Adjustments: | Business Combination-Related Costs | 1 | 4 | 1 | 3 | 0.01 |
| Non-GAAP Adjustments: | Fair Value and Credit Risk Adjustments | -4 | ||||
| Non-GAAP Adjustments: | Income Tax-Related Adjustments (b) | 107 | -107 | -0.54 | ||
| Non-GAAP Adjustments: | Adjusted Non-GAAP | 523 | 170 | 35 | 105 | 0.52 |
| Non-GAAP Adjustments: | GAAP Margin | 52.4 | -13.7 | |||
| Non-GAAP Adjustments: | Adjusted Non-GAAP Margin | 55.9 | 18.2 |
Income Statement
Three Months Ended September 30, 2025 — Percentages are based on actual values and may not reconcile due to rounding.
| Three Months Ended September 30, 2025 – Gross Profit | Three Months Ended September 30, 2025 – Operating (Loss) Income | Three Months Ended September 30, 2025 – (Benefit) Provision for Income Taxes | Three Months Ended September 30, 2025 – Net (Loss) Income Attributable to Dentsply Sirona | Three Months Ended September 30, 2025 – Diluted (Loss) Earnings per Share | ||
|---|---|---|---|---|---|---|
| GAAP | 441 | -218 | 198 | -427 | -2.14 | |
| Non-GAAP Adjustments: | Amortization of Purchased Intangible Assets | 33 | 56 | 15 | 41 | 0.21 |
| Non-GAAP Adjustments: | Restructuring-Related Charges and Other Costs (a) | 1 | 17 | -3 | 20 | 0.1 |
| Non-GAAP Adjustments: | Goodwill and Intangible Asset Impairments | 262 | -1 | 263 | 1.31 | |
| Non-GAAP Adjustments: | Business Combination-Related Costs | 2 | 1 | 1 | 0.01 | |
| Non-GAAP Adjustments: | Income Tax-Related Adjustments (b) | -186 | 186 | 0.93 | ||
| Non-GAAP Adjustments: | Adjusted Non-GAAP | 475 | 119 | 24 | 84 | 0.42 |
| Non-GAAP Adjustments: | GAAP Margin | 48.8 | -24 | |||
| Non-GAAP Adjustments: | Adjusted Non-GAAP Margin | 52.6 | 13.2 |
Income Statement
Three Months Ended December 31, 2025 — Percentages are based on actual values and may not reconcile due to rounding.
| Three Months Ended December 31, 2025 – Gross Profit | Three Months Ended December 31, 2025 – Operating (Loss) Income | Three Months Ended December 31, 2025 – (Benefit) Provision for Income Taxes | Three Months Ended December 31, 2025 – Net (Loss) Income Attributable to Dentsply Sirona | Three Months Ended December 31, 2025 – Diluted (Loss) Earnings per Share | ||
|---|---|---|---|---|---|---|
| GAAP | 443 | -139 | -2 | -146 | -0.74 | |
| Reported percent net sales | 46.2 | -14.5 | ||||
| Non-GAAP Adjustments: | Amortization of Purchased Intangible Assets | 33 | 56 | 15 | 41 | 0.21 |
| Non-GAAP Adjustments: | Restructuring-Related Charges and Other Costs (a) | 2 | 15 | 9 | 6 | 0.04 |
| Non-GAAP Adjustments: | Goodwill and Intangible Asset Impairments | 153 | 9 | 144 | 0.72 | |
| Non-GAAP Adjustments: | Business Combination-Related Costs and Fair Value Adjustments | 1 | 1 | 1 | ||
| Non-GAAP Adjustments: | Income Tax-Related Adjustments (b) | 2 | -2 | -0.01 | ||
| Non-GAAP Adjustments: | Adjusted | 479 | 86 | 33 | 44 | 0.22 |
| Non-GAAP Adjustments: | Adjusted percent of net sales | 49.8 | 8.9 |
Income Statement
Twelve Months Ended December 31, 2025 — Percentages are based on actual values and may not reconcile due to rounding.
| Twelve Months Ended December 31, 2025 – Gross Profit | Twelve Months Ended December 31, 2025 – Operating (Loss) Income | Twelve Months Ended December 31, 2025 – (Benefit) Provision for Income Taxes | Twelve Months Ended December 31, 2025 – Net (Loss) Income Attributable to Dentsply Sirona | Twelve Months Ended December 31, 2025 – Diluted (Loss) Earnings per Share | ||
|---|---|---|---|---|---|---|
| GAAP | 1,840 | -422 | 112 | -598 | -3 | |
| Reported percent net sales | 50 | -11.5 | ||||
| Non-GAAP Adjustments: | Amortization of Purchased Intangible Assets | 126 | 211 | 56 | 155 | 0.78 |
| Non-GAAP Adjustments: | Restructuring-Related Charges and Other Costs (a) (b) | 3 | 61 | 13 | 44 | 0.22 |
| Non-GAAP Adjustments: | Goodwill and Intangible Asset Impairments | 650 | 30 | 620 | 3.1 | |
| Non-GAAP Adjustments: | Business Combination-Related Costs and Fair Value Adjustments | 2 | 8 | 2 | 6 | 0.03 |
Income Statement
Q1 2026 Summary Results (Reported) (in millions, except per share amount and percentages)
| Q1 26 | Q1 25 | YoY | |
|---|---|---|---|
| Net Sales | 880 | 879 | 0.1% |
| Gross Profit | 427 | 466 | -8.3% |
| Gross Margin | 48.5% | 53.0% | |
| Net (Loss) Income Attributable to Dentsply Sirona | -10 | 20 | NM |
| Diluted (Loss) Earnings Per Share1 | -0.05 | 0.1 | NM |
Income Statement
Three Months Ended March 31, — (unaudited)
| Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 | ||
|---|---|---|---|
| Net sales | 880 | 879 | |
| Cost of products sold | 453 | 413 | |
| Gross profit | 427 | 466 | |
| Selling, general, and administrative expenses | 351 | 358 | |
| Research and development expenses | 44 | 36 | |
| Restructuring and other costs | 67 | 9 | |
| Operating (loss) income | -35 | 63 | |
| Other income and expenses: | Interest expense, net | 24 | 19 |
| Other income and expenses: | Other (income) expense, net | -17 | |
| Other income and expenses: | (Loss) income before income taxes | -42 | 44 |
| Other income and expenses: | (Benefit) provision for income taxes | -32 | 25 |
| Other income and expenses: | Net (loss) income | -10 | 19 |
| Other income and expenses: | Less: Net loss attributable to noncontrolling interest | -1 | |
| Other income and expenses: | Net (loss) income attributable to Dentsply Sirona | -10 | 20 |
| (Loss) earnings per common share attributable to Dentsply Sirona: | Basic | -0.05 | 0.1 |
| (Loss) earnings per common share attributable to Dentsply Sirona: | Diluted | -0.05 | 0.1 |
| Weighted average common shares outstanding: | Basic | 199.9 | 199.1 |
| Weighted average common shares outstanding: | Diluted | 199.9 | 199.8 |
Income Statement
Three Months Ended March 31, 2026
| Three Months Ended March 31, 2026 – Gross Profit | Three Months Ended March 31, 2026 – Operating (Loss) Income | Three Months Ended March 31, 2026 – (Benefit) Provision for Income Taxes | Three Months Ended March 31, 2026 – Net (loss) Income Attributable to Dentsply Sirona | Three Months Ended March 31, 2026 – Diluted (Loss) Earnings per Share | ||
|---|---|---|---|---|---|---|
| Reported | 427 | -35 | -32 | -10 | -0.05 | |
| Reported percent net sales | 48.5 | -4 | ||||
| Non-GAAP Adjustments: | Amortization of Purchased Intangible Assets | 19 | 42 | 11 | 31 | 0.15 |
| Non-GAAP Adjustments: | Restructuring-Related Charges and Other Costs (a) (b) | 1 | 74 | 18 | 50 | 0.25 |
| Non-GAAP Adjustments: | Income Tax-Related Adjustments (c) | 17 | -17 | -0.08 | ||
| Non-GAAP Adjustments: | Adjusted | 447 | 81 | 14 | 54 | 0.27 |
| Non-GAAP Adjustments: | Adjusted percent net sales | 50.7 | 9.2 |
Income Statement
Three Months Ended March 31, 2025 — Percentages are based on actual values and may not reconcile due to rounding.
| Three Months Ended March 31, 2025 – Gross Profit | Three Months Ended March 31, 2025 – Operating (loss) income | Three Months Ended March 31, 2025 – (Benefit) Provision for Income Taxes | Three Months Ended March 31, 2025 – Net Income Attributable to Dentsply Sirona | Three Months Ended March 31, 2025 – Diluted Earnings per Share | ||
|---|---|---|---|---|---|---|
| Reported | 466 | 63 | 25 | 20 | 0.1 | |
| Reported percent net sales | 53 | 7.1 | ||||
| Non-GAAP Adjustments: | Amortization of Purchased Intangible Assets | 28 | 45 | 12 | 33 | 0.16 |
| Non-GAAP Adjustments: | Restructuring-Related Charges and Other Costs (a) | 25 | 6 | 19 | 0.1 | |
| Non-GAAP Adjustments: | Business Combination-Related Costs | 1 | 1 | 1 | ||
| Non-GAAP Adjustments: | Income Tax-Related Adjustments (b) | -15 | 15 | 0.08 | ||
| Non-GAAP Adjustments: | Adjusted | 495 | 134 | 28 | 88 | 0.44 |
| Non-GAAP Adjustments: | Adjusted percent net sales | 56.3 | 15.1 |
Income Statement
Three Months Ended March 31, — Reconciliations of reported net (loss) income attributable to Dentsply Sirona to adjusted EBITDA and margin are as follows:
| Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 | |
|---|---|---|
| Net (loss) income attributable to Dentsply Sirona | -10 | 20 |
| Interest expense, net | 24 | 19 |
| (Benefit) provision for income taxes | -32 | 25 |
| Depreciation(1) | 38 | 33 |
| Amortization of intangible assets | 41 | 45 |
| Restructuring-related charges and other costs | 68 | 25 |
| Business combination-related costs and fair value adjustments | 1 | |
| Adjusted EBITDA | 129 | 168 |
| Net sales | 880 | 879 |
| Adjusted EBITDA margin | 14.7 | 19 |
Balance Sheet
March 31, 2026 — (unaudited)
| March 31, 2026 | December 31, 2025 | ||
|---|---|---|---|
| Current Assets: | Cash and cash equivalents | 190 | 326 |
| Current Assets: | Accounts and notes receivable-trade, net | 622 | 688 |
| Current Assets: | Inventories, net | 659 | 642 |
| Current Assets: | Prepaid expenses and other current assets | 374 | 367 |
| Current Assets: | Total Current Assets | 1,845 | 2,023 |
| Current Assets: | Property, plant, and equipment, net | 858 | 861 |
| Current Assets: | Operating lease right-of-use assets, net | 139 | 139 |
| Current Assets: | Identifiable intangible assets, net | 924 | 974 |
| Current Assets: | Goodwill | 1,142 | 1,148 |
| Current Assets: | Other noncurrent assets | 321 | 284 |
| Current Assets: | Total Assets | 5,229 | 5,429 |
| Current Liabilities: | Accounts payable | 259 | 300 |
| Current Liabilities: | Accrued liabilities | 688 | 700 |
| Current Liabilities: | Income taxes payable | 30 | 30 |
| Current Liabilities: | Notes payable and current portion of long-term debt | 230 | 313 |
| Current Liabilities: | Total Current Liabilities | 1,207 | 1,343 |
| Current Liabilities: | Long-term debt | 2,006 | 2,015 |
| Current Liabilities: | Operating lease liabilities | 95 | 93 |
| Current Liabilities: | Deferred income taxes | 84 | 94 |
| Current Liabilities: | Other noncurrent liabilities | 518 | 544 |
| Current Liabilities: | Total Liabilities | 3,910 | 4,089 |
| Current Liabilities: | Total Equity | 1,319 | 1,340 |
| Current Liabilities: | Total Liabilities and Equity | 5,229 | 5,429 |
Cash Flow
Three Months Ended March 31, — A reconciliation of free cash flow for the three months ended March 31, 2026 and 2025 is as follows:
| Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 | |
|---|---|---|
| Net cash provided by operating activities | 40 | 7 |
| Capital expenditures | -52 | -19 |
| Free cash flow | -12 | -12 |
Full release
Forward-Looking Statements and Associated Risks... (truncated)-K, Part II, Item 1A, "Risk Factors" of the Company's Quarterly Reports on Form 10-Q for any subsequent fiscal quarters, and any updating information or other factors which may be described in the Company's other filings with the Securities and Exchange Commission (the "SEC"). No assurance can be given that any expectation, belief, goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this Press Release or to reflect the occurrence of unanticipated events. Investors should understand it is not possible to predict or identify all such factors or risks. As such, you should not consider the risks identified in the Company's SEC filings to be a complete discussion of all potential risks or uncertainties associated with an investment in the Company.